Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma

Biomaterials

Volumn 32, Issue 18, 2011, Pages 4293-4305

  Xin, Hongliang ^a   Jiang, Xinyi ^a   Gu, Jijin ^a   Sha, Xianyi ^a   Chen, Liangcen ^a   Law, Kitki ^a   Chen, Yanzuo ^a   Wang, Xiao ^a   Jiang, Ye ^a   Fang, Xiaoling ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiopep; Blood brain barrier; Brain glioma; Dual targeting; LRP; PTX

Indexed keywords

ANGIOPEP; BLOOD-BRAIN BARRIER; DUAL TARGETING; LRP; PTX;

BLOOD; CELL DEATH; DRUG DELIVERY; ETHYLENE; ETHYLENE GLYCOL; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

TUMORS;

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MACROGOL; NANOPARTICLE; PACLITAXEL;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; GLIOMA; GLIOMA CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PEPTIDES; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 79955104821     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.044     Document Type: Article

References (64)

1. Allard E., Passirani C., Benoit J.P. Convection-enhanced delivery of nanoparticles for the treatment for brain tumors. Biomaterials 2009, 30:2302-2318.
2. Ong B.Y., Ranganath S.H., Lee L.Y. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Biomaterials 2009, 30:3189-3196.
3. Pardridge W.M. BBB-Genomics: creating new openings for brain-drug targeting. Drug Discov Today 2001, 6:381-383.
4. Pardridge W.M. Crossing the blood-brain barrier: are we getting it right?. Drug Discov Today 2001, 6(1):1-2.
5. Pardridge W.M. The lack of BBB research. Drug Discov Today 2002, 7(4):223-226.
6. Minchinton A.I., Tannock I.F. Drug penetration in solid tumors. Nat Rev Cancer 2006, 6:583-592.
7. Dhanikula R.S., Argaw A., Bouchard J.F., Hildgen P. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. Mol Pharm 2008, 5(1):105-116.
8. McCarthy J.R., Weissleder R. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 2008, 60(11):1241-1251.
9. Koo Y.E., Reddy G.R., Bhojani M., Schneider R., Philbert M.A., Rehemtulla A., et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 2006, 58(14):1556-1577.
10. Moghimi S.M., Hunter A.C., Murray J.C. Nanomedicine: current status and future prospects. FASEB J 2005, 19(3):311-330.
11. Xin H.L., Chen L.C., Gu J.J., Ren X.Q., Zhang W., Luo J.Q., et al. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly (ε-caprolactone) nanoparticles: in vitro and in vivo evaluation. Int J Pharm 2010, 402:238-247.
12. Smith M.W., Gumbleton M. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies. J Drug Target 2006, 14:191-214.
13. Visser C.C., Voorwinden L.H., Crommelin D.J., Danhof M., de Boer A.G. Characterization and modulation of the transferrin receptor on brain capillary endothelial cells. Pharm Res 2004, 21(5):761-769.
14. Gabathuler R., Arthur G., Kennard M., Chen Q., Tsai S., Yang J., et al. Development of a potential protein vector (NeuroTrans) to deliver drugs across to the blood-brain barrier. Int Congr Ser 2005, 1277:171-184.
15. Muruganandam A., Tanha J., Narang S., Stanimirovic D. Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J 2002, 16(2):240-242.
16. Pang Z.Q., Feng L., Hua R.Q., Chen J., Gao H.L., Pan S.Q., et al. Lactoferrin-conjugated biodegradable polymersome holding doxorubicin and tetrandrine for chemotherapy of glioma rats. Mol Pharm 2010, 7(6):1995-2005.
17. Bell R.D., Sagare A.P., Friedman A.E., Bedi G.S., Holtzman D.M., Deane R., et al. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 2007, 27:909-918.
18. Fillebeen C., Descamps L., Dehouck M.P. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 1999, 274(11):7011-7017.
19. Demeule M., Poirier J., Jodoin J., Bertrand Y., Desrosiers R.R., Dagenais C., et al. High transcytosis of melanotransferrin (p97) across the blood-brain barrier. J Neurochem 2002, 83:924-933.
20. Pan W., Kastin A.J., Zankel T.C., van Kerkhof P., Terasaki T., Bu G., et al. Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier. J Cell Sci 2004, 117:5071-5078.
21. Maletinska L., Blakely E.A., Bjornstad K.A. Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low density lipoprotein receptor-related protein. Cancer Res 2000, 60:2300-2303.
22. Yamamoto M., Ikeda K., Oshshima K., Tsugo H., Kimura H., Tomonaga M., et al. Increased expression of low density lipoprotein receptor-related protein/α2- macroglobulin receptor in human malignant astrocytomas. Cancer Res 1997, 57:2799-2805.
23. Bu G., Maksymovitch E.A., Geuze H., Schwartz A.L. Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J Biol Chem 1994, 269:29874-29882.
24. Demeule M., Régina A., Ché C., Poirier J., Nguyen T., Gabathuler R., et al. Identification and design of peptides as a new drug delivery system for the brain. J Pharmacol Exp Ther 2008, 324(3):1064-1072.
25. Demeule M., Currie J.C., Bertrand Y., Ché C., Nguyen T., Régina A., et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008, 106(4):1534-1544.
26. Ke W.L., Shao K., Huang R.Q., Han L., Liu Y., Li J.F., et al. Gene delivery targeted to brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. Biomaterials 2009, 30(36):6976-6985.
27. Shen J., Zhan C.Y., Xie C., Meng Q.G., Gu B., Li C., et al. Poly(ethylene glycol)-block-poly(d, l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery. J Drug Target 2010, 6:1-8.
28. Régina A., Demeule M., Ché C., Lavallée I., Poirier J., Gabathuler R., et al. Antitumor activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2. Br J Pharmacol 2008, 155:185-197.
29. Desai A., Vyas T., Amiji M. Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations. J Pharm Sci 2008, 97:2745-2756.
30. Chang S.M., Kuhn J.G., Robins H.I., Schold S.C., Spence A.M., Berger M.S., et al. A Phase I{cyrillic, ukrainian}I{cyrillic, ukrainian} study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a north American brain tumor consortium report. Cancer 2001, 91:417-422.
31. Postma T.J., Heimans J.J., Luykx S.A., van Groeningen C.J., Beenen L.F., Hoekstra O.S., et al. A phase I{cyrillic, ukrainian}I{cyrillic, ukrainian} study of paclitaxel in chemonaive patients with recurrent high-grade. Ann Oncol 2000, 11:409-413.
32. Pang Z.Q., Lu W., Gao H.L., Hu K.L., Chen J., Zhang C.L., et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. J Control Release 2008, 128:120-127.
33. Meng F., Engbers G.H.M., Feijen J. Biodegradable polymersomes as a basis for artificial cells: encapsulation, release and targeting. J Control Release 2005, 101:187-198.
34. Zhu Z.S., Li Y., Li X.L., Li R.T., Jia Z.J., Liu B.R., et al. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: preparation and antitumor activity in vivo. J Control Release 2010, 142:438-446.
35. Olivier J.C., Huertas R., Lee H.J., Calon F., Pardridge W.M. Synthesis of pegylated immunonanoparticles. Pharm Res 2002, 19:1137-1143.
36. Han L.M., Guo J., Zhang L.J., Wang Q.S., Fang X.L. Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel. Acta Pharmacol Sin 2006, 27:747-753.
37. Zhang W., Hao J.G., Shi Y., Li Y.J., Wu J., Sha X.Y., et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm 2009, 336:176-185.
38. Xie Y., Ye L.Y., Zhang X.B., Hou X.P., Lou J.N. Establishment of an in vitro model of Brain-blood barrier. Beijing Da Xue Xue Bao 2004, 36(4):435-438.
39. Kuhlmann C.R., Lessmann V., Luhmann H.J. Fluvastatin stabilizes the blood-brain barrier in vitro by nitric oxide-dependent dephospho-rylation of myosin light chains. Neuropharmacology 2006, 51:907-913.
40. Liu J., Shapiro J.I. Endocytosis and signal transduction: basic science update. Biol Res Nurs 2003, 5:117-128.
41. Chang J., Jallouli Y., Kroubi M., Yuan X.B., Feng W., Kang C.S., et al. Characterization of endocytosis of transferring-coated PLGA nanoparticles by the blood-brain barrier. Int J Pharm 2009, 379:285-292.
42. Aoki T., Nomura R., Fujimoto T. Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res 1999, 253:629-636.
43. Liu P., Anderson R.G. Spatial organization of EGF receptor transmodulation by PDGF. Biochem Biophys Res Commun 1999, 26:695-700.
44. Roger E., Lagarce F., Garcion E., Benoit J.P. Lipid nanocarriers improve paclitaxel transport through human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Release 2009, 140:174-181.
45. Tahara K., Sakai T., Yamamoto H., Takeuchi H., Hirashima N., Kawashima Y., et al. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009, 382:198-204.
46. Abu Lila A.S., Kizuki S., Doi Y., Suzuki T., Ishida T., Kiwada H., et al. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. J Control Release 2009, 137:8-14.
47. Xu Z.H., Chen L.L., Gu W.W., Gao Y., Lin L.P., Zhang Z.W., et al. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009, 30:226-232.
48. Nam H.Y., Kwon S.M., Chung H., Lee S.Y., Kwon S.H., Jeon H., et al. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparicles. J Control Release 2009, 135:259-267.
49. Krieger M., Herz J. Structure and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Ann Rev Biochem 1994, 63:601-637.
50. May P., Herz J., Bock H.H. Molecular mechanisms of lipoprotein receptor signalling. Cell Mol Life Sci 2005, 62(19-20):2325-2338.
51. Thomas F.C., Taskar K., Rudraraju V., Goda S., Thorsheim H.R., Gaasch J.A., et al. Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer. Pharm Res 2009, 26:2486-2494.
52. Weiss R.B., Donehower R.C., Wiernik P.H. Hypersensitivity reactions from Taxol. J Clin Oncol 1990, 8:1263-1268.
53. Ten tije A.J., Verweij J., Loos W.J., Sparreboom A. Pharmacological effects of formulation vehicles: implication for canner chemotherapy. Clin Pharmacokinet 2003, 42:665-685.
54. Bhojani M.S., Dort M.V., Rehemtulla A., Ross B.D. Targeted imaging and therapy of brain cancer using theranostic nanoparticles. Mol Pharm 2010, 7(6). 1921-9.
55. Chawla J.S., Amiji M.M. Biodegradable poly(ε-caprolactone) nanoparticles for tumor targeted delivery of tamoxifen. Int J Pharm 2002, 249:127-138.
56. Li S.D., Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 2008, 5(4):496-504.
57. Huwyler J., Wu D., Pardridge W.M. Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci 1996, 93(24):14164-14169.
58. Sahay G., Alakhova D.Y., Kabanov A.V. Endocytosis of nanomedicines. J Control Release 2010, 145:182-195.
59. Groth-Pedersen L., Ostenfeld M.S., Høyer-Hansen M., Nylandsted J., Jäättelä M. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 2007, 67(5):2217-2225.
60. Tian W., Ying X., Du J., Guo J., Men Y., Zhang Y., et al. Enhanced efficacy of functionalized epirubicin liposomes in treating brain glioma-bearing rats. Eur J Pharm Sci 2010, 41(2):232-243.
61. Ying X., Wen H., Lu W.L., Du J., Guo J., Tian W., et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 2010, 141:183-192.
62. Du J., Lu W.L., Ying X., Liu Y., Du P., Tian W., et al. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the Blood-Brain Barrier and survival of brain tumor-bearing animals. Mol Pharm 2009, 6(3):905-917.
63. Zhan C.Y., Gu B., Xie C., Li J., Liu Y., Liu W.Y., et al. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect. J Control Release 2010, 143(1):136-142.
64. Zhan C.Y., Yan Z.Q., Xie C., Lu W.Y. Loop 2 of ophiophagus hannah toxin b binds with neuronal nicotinic acetylcholine receptors and enhances intracranial drug delivery. Mol Pharm 2010, 7(6). 1940-7.